Prospective Treatment of Age-Related Diseases by Slowing Down Aging

被引：83
作者：
Blagosklonny, Mikhail V. [1 ]
机构：
[1] Roswell Pk Canc Inst, Dept of Cell Stress Biol, Buffalo, NY 14263 USA
来源：
AMERICAN JOURNAL OF PATHOLOGY | 2012年 / 181卷 / 04期
关键词：
GENETICALLY HETEROGENEOUS MICE; RENAL-TRANSPLANT RECIPIENTS; EXTENDS LIFE-SPAN; CELL-CYCLE ARREST; CALORIE RESTRICTION; INSULIN-RESISTANCE; MTOR INHIBITOR; ORAL RAPAMYCIN; SENESCENCE; HUMANS;
D O I：
10.1016/j.ajpath.2012.06.024
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Atherosclerosis, hypertension, obesity, diabetic complications, cancer, benign prostate hyperplasia, Alzheimer and Parkinson diseases, age-related macular degeneration, osteoarthritis, osteoporosis, and seborrheic keratosis are strongly associated with aging, implying a common underlying process. Each disease is treated separately and, in most cases, symptomatically. Suppression of aging itself should delay or treat all age-related diseases, thus increasing healthy life span and maximal longevity. But, is it possible to slow down aging? Recent evidence indicates that the target of rapamycin signaling pathway is involved in cellular senescence and organismal aging. Preclinical and clinical studies demonstrated the therapeutic effects of rapamycin in diverse age-related diseases. One simple reason why a single drug is indicated for so many age-related diseases is that it inhibits the aging process. (Am J Pathol 2012, 181:1142-1146; http://dx.doi.org/10.1016/j.ajpath.2012.06.024)
引用
收藏
页码：1142 / 1146
页数：5
相关论文
共 63 条
  • [1] Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
    Anisimov, Vladimir N.
    Zabezhinski, Mark A.
    Popovich, Irina G.
    Piskunova, Tatiana S.
    Semenchenko, Anna V.
    Tyndyk, Margarita L.
    Yurova, Maria N.
    Rosenfeld, Svetlana V.
    Blagosklonny, Mikhail V.
    [J]. CELL CYCLE, 2011, 10 (24) : 4230 - 4236
  • [2] Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
    Anisimov, Vladimir N.
    Zabezhinski, Mark A.
    Popovich, Irina G.
    Piskunova, Tatiana S.
    Semenchenko, Anna V.
    Tyndyk, Margarita L.
    Yurova, Maria N.
    Antoch, Marina P.
    Blagosklonny, Mikhail V.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (05) : 2092 - 2097
  • [3] Everolimus Inhibits Monocyte/Macrophage Migration in Vitro and Their Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits
    Baetta, Roberta
    Granata, Agnese
    Canavesi, Monica
    Ferri, Nicola
    Arnaboldi, Lorenzo
    Bellosta, Stefano
    Pfister, Pascal
    Corsini, Alberto
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (02) : 419 - 425
  • [4] Insulin and aging
    Bartke, Andrzej
    [J]. CELL CYCLE, 2008, 7 (21) : 3338 - 3343
  • [5] The Critical Role of Metabolic Pathways in Aging
    Barzilai, Nir
    Huffman, Derek M.
    Muzumdar, Radhika H.
    Bartke, Andrzej
    [J]. DIABETES, 2012, 61 (06) : 1315 - 1322
  • [6] Metformin, insulin, breast cancer and more ...
    Berstein, Lev M.
    [J]. FUTURE ONCOLOGY, 2009, 5 (03) : 309 - 312
  • [7] Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster
    Bjedov, Ivana
    Toivonen, Janne M.
    Kerr, Fiona
    Slack, Cathy
    Jacobson, Jake
    Foley, Andrea
    Partridge, Linda
    [J]. CELL METABOLISM, 2010, 11 (01) : 35 - 46
  • [8] Prevention of cancer by inhibiting aging
    Blagosklonny, Mikhail V.
    [J]. CANCER BIOLOGY & THERAPY, 2008, 7 (10) : 1520 - 1524
  • [9] Aging and immortality - Quasi-programmed senescence and its pharmacologic inhibition
    Blagosklonny, Mikhail V.
    [J]. CELL CYCLE, 2006, 5 (18) : 2087 - 2102
  • [10] Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging
    Blagosklonny, Mikhail V.
    [J]. AGING-US, 2012, 4 (03): : 159 - 165
1234567